| Coexistence HBsAg/HBcAC, Clinical Characterístics & Outcomes (NCT05446532) | Corporacion Parc Tauli | 2022-06-15 |
| Prevalence of HBV in Pregnancy (NCT05442372) | Sohag University | 2022-06-15 |
| Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus (NCT06360484) | National Center for Gastroentestinal and Liver Disease | 2022-06-01 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH-006 in Healthy Volunteers (NCT05275465) | Huahui Health | 2022-05-03 |
| Australian Hepatitis and Risk Survey in Prisons (NCT05839522) | Kirby Institute | 2022-04-27 |
| Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection (NCT05330455) | GlaxoSmithKline | 2022-04-14 |
| Liver Cancer Disparities in American Indian and Alaska Native Persons (NCT05304234) | University of Washington | 2022-04-01 |
| Health and Migration Trajectories of Housekeepers in Bamako (NCT05472051) | ANRS, Emerging Infectious Diseases | 2022-02-28 |
| Real World Assessment of People Living With Chronic Hepatitis B in Australia (NCT04914611) | Kirby Institute | 2022-02-17 |
| Estimation of the Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in the Nîmes Administrative Detention Center (NCT05127187) | Centre Hospitalier Universitaire de Nīmes | 2022-02-08 |
| Evaluation of Novel Point of Care Hepatitis B Diagnostic Assays (NCT04289428) | Kirby Institute | 2022-01-01 |
| Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone (NCT04710641) | Mina Alpha Limited | 2022-01-01 |
| HBV Reactivation in Anti CD20 Treatment (NCT05768061) | HaEmek Medical Center, Israel | 2021-12-16 |
| Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure) (NCT04954859) | GlaxoSmithKline | 2021-12-14 |
| Prevention of HCC Using Mobile Phone Applications (NCT05094869) | Beijing Friendship Hospital | 2021-11-15 |
| Re-compensation and Its Clinical Characteristics in HBV Decompensated Cirrhosis (NCT05086536) | Beijing Friendship Hospital | 2021-10-15 |
| Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital (NCT04959643) | University Hospital, Montpellier | 2021-10-05 |
| A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine (NCT06147895) | Aribio Lab Co., Ltd. | 2021-09-17 |
| Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment (NCT04971928) | GlaxoSmithKline | 2021-09-07 |
| The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort (NCT04970836) | National Taiwan University Hospital | 2021-08-01 |
| Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects (NCT04906109) | Dong-A ST Co., Ltd. | 2021-07-12 |
| Cameroon HepB Birth Dose Feasibility Pilot (NCT04893616) | Clinton Health Access Initiative Inc. | 2021-06-10 |
| Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets (NCT04868981) | Fujian Cosunter Pharmaceutical Co. Ltd | 2021-05-31 |
| Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D) (NCT04863703) | Hannover Medical School | 2021-05-07 |
| A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection (NCT04585789) | Janssen Research & Development, LLC | 2021-03-11 |
| Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening (NCT04659005) | Chinese University of Hong Kong | 2021-02-01 |
| Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) (NCT04676724) | GlaxoSmithKline | 2021-01-28 |
| Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B. (NCT04114890) | University of Oxford | 2021-01-08 |
| First-In-Human Study of ChAdOx1-HBV & MVA-HBV Vaccines (VTP-300) for Chronic HBV (NCT04778904) | Barinthus Biotherapeutics | 2020-12-22 |
| B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B (NCT04193189) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-12-14 |
| Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population (NCT06379334) | Peking Union Medical College Hospital | 2020-12-06 |
| Combi-elastography Assessment of Chronic Liver Disease Multi-center Study (NCT04625166) | Chinese PLA General Hospital | 2020-12-01 |
| Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects (NCT04783753) | Enanta Pharmaceuticals, Inc | 2020-11-05 |
| Neonatal Vaccination Against Hepatitis B in Africa - Sero-survey in Senegal (NCT03829735) | Institut Pasteur | 2020-11-01 |
| A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B (NCT04544956) | GlaxoSmithKline | 2020-10-06 |
| Hep Mec Cohort in Zambia (NCT07589985) | University of Alabama at Birmingham | 2020-09-28 |
| Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis (NCT04588077) | Mercy Medical Center | 2020-09-14 |
| A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013) (NCT04490499) | Merck Sharp & Dohme LLC | 2020-09-02 |
| Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 Tablets (NCT04499443) | Fujian Cosunter Pharmaceutical Co. Ltd | 2020-08-18 |
| A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB) (NCT04449029) | GlaxoSmithKline | 2020-07-27 |
| Assessing the Reliability of Self-Reported Hepatitis B Vaccination Status in Outpatients: Evaluation of Individuals Born in France and Consulting at the CeGIDD in Saint-Denis. (NCT06998992) | Centre Hospitalier de Saint-Denis | 2020-07-01 |
| A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B (NCT04568265) | Ascentage Pharma Group Inc. | 2020-06-03 |
| Hepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine Response (NCT04326803) | Pontificia Universidad Catolica de Chile | 2020-06-01 |
| Study on the Tolerance and Pharmacokinetics of GST-HG141 Tablets (NCT04386915) | Fujian Cosunter Pharmaceutical Co. Ltd | 2020-05-18 |
| Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure (NCT04310787) | Third Affiliated Hospital, Sun Yat-Sen University | 2020-05-15 |
| Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects (NCT04309526) | Nucorion Pharmaceuticals, Inc. | 2020-03-18 |
| Liver Disease and Other Systemic Diseases (NCT04525833) | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation | 2020-01-01 |
| Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children (NCT04188223) | PT Bio Farma | 2019-12-03 |
| Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed Patients (NCT04199715) | Baylor Research Institute | 2019-12-03 |
| RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLF (NCT04195282) | Third Affiliated Hospital, Sun Yat-Sen University | 2019-12-01 |
| Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis (NCT03957629) | Third Affiliated Hospital, Sun Yat-Sen University | 2019-11-06 |
| Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants (NCT04073459) | LG Chem | 2019-11-01 |
| Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders (NCT05791851) | University of Maryland, Baltimore | 2019-10-23 |
| Preliminary Validation of an in Vitro Diagnosis-medical Device for Hepatitis B Screening (NCT04109625) | University Hospital, Grenoble | 2019-10-21 |
| Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus (NCT04059198) | F-star Therapeutics, Inc. | 2019-10-10 |
| A Phase IV Study to Assess the Safety of EupentaTM Inj (NCT04056728) | LG Chem | 2019-09-23 |
| Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC (NCT03897946) | University of North Carolina, Chapel Hill | 2019-08-20 |
| Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B (NCT03933384) | Taichung Veterans General Hospital | 2019-08-19 |
| Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients (NCT04083157) | The University of Hong Kong | 2019-08-12 |
| A Study in Healthy Volunteers (NCT03596697) | Hepion Pharmaceuticals, Inc. | 2019-07-09 |
| Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg) (NCT04075201) | Sinovac Biotech Co., Ltd | 2019-07-07 |
| Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic, Hepatitis B e Antigen-negative Subjects Infected With HBV Virus and Receiving or Stopping Treatment With a NUC Inhibitor (NCT04023721) | F-star Therapeutics, Inc. | 2019-06-18 |
| Switching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil Maleate (NCT04202536) | IlDong Pharmaceutical Co Ltd | 2019-05-29 |
| Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer (NCT05181826) | Helio Genomics | 2019-05-21 |
| B/F/TAF Switch Study for HIV-HBV Coinfection (NCT03797014) | University of Maryland, Baltimore | 2019-04-30 |
| Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients (NCT03932513) | F-star Therapeutics, Inc. | 2019-04-11 |
| HBV/HCV/HIV in Belgian Prisons (NCT04366492) | Hasselt University | 2019-04-01 |
| Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure. (NCT03825458) | Hospices Civils de Lyon | 2019-02-25 |
| Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF (NCT03920618) | Third Affiliated Hospital, Sun Yat-Sen University | 2019-02-21 |
| First in Human Study of ChAdOx1-HBV in Healthy Participants and Participants With Chronic hepB Infection (NCT04297917) | Barinthus Biotherapeutics | 2019-02-10 |
| Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver Fibrosis (NCT03920605) | Third Affiliated Hospital, Sun Yat-Sen University | 2019-02-01 |
| Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver Fibrosis (NCT03919565) | Third Affiliated Hospital, Sun Yat-Sen University | 2019-02-01 |
| The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure (NCT03640728) | First Affiliated Hospital Xi'an Jiaotong University | 2019-01-25 |
| Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment (NCT03577938) | Beijing 302 Hospital | 2019-01-10 |
| Epidemiology of Hepatitis B, C and Delta in Reunion Island (NCT03362866) | Centre Hospitalier Universitaire de la Réunion | 2019-01-01 |
| Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated Cirrhosis (NCT04196998) | Third Affiliated Hospital, Sun Yat-Sen University | 2019-01-01 |
| Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population (NCT03702998) | Chinese University of Hong Kong | 2018-12-01 |
| Reaching Out to the UNdiagnosed People Infected With Blood Borne Viral Infections (NCT04363411) | Hasselt University | 2018-10-25 |
| An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection (NCT03692897) | Target PharmaSolutions, Inc. | 2018-10-11 |
| hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis (NCT03826433) | Sclnow Biotechnology Co., Ltd. | 2018-10-01 |
| Arresting Vertical Transmission of Hepatitis B Virus (NCT03567382) | University of North Carolina, Chapel Hill | 2018-09-24 |
| Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver (NCT03604016) | IlDong Pharmaceutical Co Ltd | 2018-09-23 |
| Switching From Tenofovir Disoproxi Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Antiviral Resistance (NCT03566030) | Yonsei University | 2018-09-01 |
| Study to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001 (NCT03625934) | Viravaxx AG | 2018-08-06 |
| Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B Infection (NCT03343431) | Institut de Recherche pour le Developpement | 2018-08-02 |
| Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis (NCT03620474) | Kiminori Kimura, MD | 2018-07-24 |
| Mild Hypothermia and Acute Kidney Injury in Liver Transplantation (NCT03534141) | University of California, San Francisco | 2018-07-07 |
| Evaluation of an Infant Immunization Encouragement Program in Nigeria (NCT03870061) | GiveWell | 2018-07-01 |
| Stop Hep B @ Birth (NCT04998838) | Myanmar Liver Foundation | 2018-07-01 |
| Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children (NCT04294433) | Laval University | 2018-06-11 |
| Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus (NCT02995005) | Johns Hopkins Bloomberg School of Public Health | 2018-05-24 |
| Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV) (NCT03680183) | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 2018-05-22 |
| Crowdsourcing to Promote HBV and HCV Testing in China (NCT03482388) | University of North Carolina, Chapel Hill | 2018-05-09 |
| Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines (NCT03410953) | Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León | 2018-04-13 |
| Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant (NCT03511794) | National Heart, Lung, and Blood Institute (NHLBI) | 2018-04-13 |
| Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV) (NCT03365947) | Arrowhead Pharmaceuticals | 2018-03-27 |
| The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks (NCT03931239) | Vabiotech | 2018-03-01 |
| An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection (NCT03361956) | Janssen Sciences Ireland UC | 2018-02-13 |
| Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection (NCT03312023) | University of Maryland, Baltimore | 2018-02-01 |
| A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers (NCT03568578) | Peking University First Hospital | 2018-01-28 |